Glancy Prongay & Murray LLP Announces Investigation of Inspire Medical Systems, Inc. (INSP)

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Inspire Medical Systems, Inc. (NYSE: INSP) concerning the Company and its directors’ and officers’ possible violations of state laws.

If you own Inspire Medical Systems stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy@glancylaw.com, or at 212-682-5340. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  240.90
+8.21 (3.53%)
AAPL  283.99
+0.21 (0.07%)
AMD  526.91
+5.33 (1.02%)
BAC  58.06
+0.18 (0.32%)
GOOG  345.12
+10.44 (3.12%)
META  568.73
+18.48 (3.36%)
MSFT  378.20
+5.23 (1.40%)
NVDA  195.89
+3.36 (1.75%)
ORCL  153.40
+4.87 (3.28%)
TSLA  393.42
+13.71 (3.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.